Related by context. All words. (Click for frequent words.) 78 adenoma 74 advanced adenomas 74 polyps 74 colorectal polyps 71 adenomatous polyps 70 advanced adenoma 70 colorectal neoplasms 70 colon polyps 67 endometrial cancers 67 colorectal adenomas 67 adenocarcinomas 67 pre cancerous polyps 67 metastases 67 precancerous lesions 66 lymph node metastases 66 hyperplastic polyps 65 neoplasms 64 neoplasia 64 atypical hyperplasia 64 pre cancerous growths 64 microbleeds 64 benign growths 64 prostate cancers 64 colorectal polyp 64 advanced neoplasia 64 malignant polyps 64 breast cancers 63 tumors 63 colorectal neoplasia 63 colorectal tumors 63 precancerous polyp 63 lung nodules 63 thyroid nodules 63 lesions 63 bowel cancers 63 ductal cancer 63 PCa 63 melanomas 63 polyp 63 precancerous polyps 62 micrometastases 62 endometrial hyperplasia 62 Adenomas 62 tumor recurrence 62 metastatic lesions 62 Polyps 62 renal cell carcinomas 62 lung tumors 62 GISTs 62 carcinoma 62 colorectal adenoma 62 polyp recurrence 62 lobular cancer 62 NP CRNs 62 colon tumors 62 benign breast 62 NAFLD 62 elevated CRP 62 precancerous growths 62 breast tumors 62 lobular carcinoma 62 uterine cancers 62 endometrial cancer 62 bladder cancers 62 HGPIN 62 adenocarcinoma 61 colonic polyps 61 esophageal cancers 61 colorectal cancer 61 lung lesions 61 malignant growths 61 invasive breast cancer 61 neoplasm 61 microalbuminuria 61 prostate cancer CaP 61 colorectal cancers 61 proximal colon 61 metastatic disease 61 benign polyps 61 benign lesions 61 basal cell carcinomas 61 contralateral breast 61 BRCA1 mutations 61 biochemical recurrence 61 colorectal carcinoma 61 cancerous polyps 61 atypia 61 sentinel nodes 61 malignancy 61 premalignant 61 subclinical hyperthyroidism 61 breast lesions 61 intestinal polyps 60 pulmonary metastases 60 malignant nodules 60 subclinical hypothyroidism 60 renal tumors 60 situ LCIS 60 malignancies 60 distant metastases 60 hyperplastic 60 colon cancers 60 adenomatous 60 abnormal growths 60 leiomyomas 60 DCIS lesions 60 Barrett esophagus 60 varices 60 serum PSA 60 pre cancerous lesions 60 mammary tumors 60 lymph node involvement 60 pCR 60 ALND 60 serrated polyps 60 liver metastases 60 urothelial carcinoma 60 carcinoid tumor 60 CIN2 + 60 atherosclerotic lesions 60 nodules 60 metachronous 60 brain metastases 60 asymptomatic 60 cancerous lesions 60 lobular breast cancer 59 malignant lesions 59 cervical lesions 59 precursor lesions 59 squamous cell carcinomas 59 thromboembolic events 59 colorectal cancer CRC 59 uveal melanoma 59 bowel polyps 59 liver metastasis 59 axillary lymph nodes 59 esophageal adenocarcinoma 59 carcinomas 59 nonmelanoma skin cancers 59 invasive carcinoma 59 premenopausal breast cancer 59 lung cancers 59 grade dysplasia 59 PSADT 59 gallstone disease 59 meningiomas 59 recurrent VTE 59 BRCA mutations 59 medullary thyroid cancer 59 nonmelanoma skin cancer 59 gastric adenocarcinoma 59 grade gliomas 59 pancreatic cancers 59 hamartomas 59 squamous cell cancers 59 carotid stenosis 58 MGUS 58 adenoma recurrence 58 axillary node dissection 58 ovarian tumors 58 colorectal liver metastases 58 EBRT 58 dysplastic 58 distant metastasis 58 breast cancer recurrence 58 rectal cancers 58 prostate adenocarcinoma 58 ductal carcinomas 58 oophorectomy 58 upper endoscopy 58 definite stent thrombosis 58 breast carcinoma 58 ductal carcinoma 58 squamous cell 58 contralateral breast cancer 58 preoperative chemotherapy 58 rectal cancer 58 basal cell nevus syndrome 58 CaP 58 venous thromboembolism 58 polypoid 58 ductal breast cancer 58 BRCA1 mutation carriers 58 CIN3 + 58 nevi 58 pre cancerous cells 58 radioiodine therapy 58 epithelial tumors 58 nodal metastases 58 upper gastrointestinal bleeding 58 meningioma 58 atypical ductal hyperplasia 58 HER2 amplification 58 extracapsular extension 58 ovarian cancers 58 thyroid nodule 58 postmenopausal breast cancer 57 poorer prognosis 57 metastatic prostate cancer 57 polyp detection 57 HNSCC 57 pT2 57 neoplastic lesions 57 vertebral fracture 57 mesotheliomas 57 estrogen receptor negative 57 coronary calcification 57 fibroadenomas 57 transferrin saturation 57 EGFR mutations 57 KRAS mutations 57 intestinal metaplasia 57 papillary 57 cell carcinomas 57 cancers 57 ductal 57 uterine tumors 57 prostate tumors 57 Papillary 57 periodontitis 57 distal colon cancer 57 deep venous thrombosis 57 breast carcinomas 57 radical nephrectomy 57 abnormalities 57 colon rectal 57 venous thrombosis 57 preterm delivery 57 pleomorphic 57 SUVmax 57 histologically 57 nodal metastasis 57 premalignant lesions 57 mammographically 57 endometrial carcinoma 57 undergoing radical prostatectomy 57 clinically insignificant 57 troponin T 57 albuminuria 57 BRCA2 mutations 57 premenopausal 57 lipomas 57 paraganglioma 57 glandular tissue 57 gastric cancers 57 squamous cell carcinoma 57 flexible sigmoidoscopy 57 grade cervical intraepithelial 57 PSA velocity 57 prostate carcinoma 57 situ DCIS 57 extracolonic findings 57 gastrointestinal cancers 57 Rectal cancer 57 precancer 57 ischemic lesions 57 thromboembolism 57 distal colon 57 invasive ductal 56 optical colonoscopy 56 GSTT1 56 systolic dysfunction 56 beta blocker therapy 56 serous ovarian cancer 56 testicular tumors 56 ADPKD 56 drusen 56 p# mutations 56 lymph node metastasis 56 epithelial ovarian cancer 56 BRAF mutations 56 Hurthle cell 56 lung nodule 56 #.#ng/ml 56 KRAS mutation 56 infarcts 56 mucinous 56 GSTM1 56 node metastases 56 lung metastasis 56 CC genotype 56 macroalbuminuria 56 coronary disease 56 benign tumors 56 BRCA mutation carriers 56 calcifications 56 underwent radical prostatectomy 56 oropharyngeal cancer 56 nonvertebral fractures 56 nonsmall cell lung cancer 56 invasive carcinomas 56 acoustic neuroma 56 poor metabolizers 56 hyperoxaluria 56 androgen deprivation 56 MACCE 56 rebleeding 56 de ath 56 CIN3 56 ultrasonographic 56 bone metastasis 56 colon adenomas 56 seminomas 56 malignant tumors 56 testicular cancers 56 Helicobacter pylori infection 56 Tumours 56 GI bleeding 56 Carcinoma 56 LQTS 56 pulmonary nodules 56 prostate cancer PCa 56 oesophageal cancer 56 Tumors 56 lung metastases 56 cutaneous melanoma 56 peritoneal carcinomatosis 56 cell carcinoma 56 lung carcinomas 56 amyloid deposits 56 nonfatal MI 56 precancerous cervical 56 gastrectomy 56 nephrectomy 56 resectable 56 BRCA2 mutation carriers 56 hamartoma 56 lymphadenectomy 56 cervical carcinoma 56 vertebral fractures 56 occult metastases 56 polypoid lesions 56 neoplasias 56 chromosomal abnormalities 56 thyroid carcinoma 56 acoustic neuromas 56 sarcosine 56 malignant lymphoma 56 nondiabetic 55 malignant lesion 55 neuroblastomas 55 vulvar intraepithelial neoplasia 55 glucose intolerance 55 carcinoid tumors 55 asymptomatic carotid stenosis 55 cognitively normal 55 untreated celiac disease 55 dysplasia 55 axillary nodes 55 osteosarcomas 55 hematopoietic cancers 55 bilateral oophorectomy 55 melanoma 55 colectomy 55 differentiated thyroid 55 serum creatinine levels 55 prostate tumor 55 HER2 positive tumors 55 GSTP1 55 ABCB1 55 precancerous tumors 55 pre cancerous lesion 55 axillary node 55 renal artery stenosis 55 axillary dissection 55 folic acid takers 55 Kaplan Meier analysis 55 axillary lymph node dissection 55 carotid plaque 55 DCIS 55 micrometastasis 55 MetS 55 laryngeal cancer 55 lobular 55 vestibular schwannomas 55 perioperative complications 55 pre cancerous adenomas 55 IDH1 mutation 55 BRAF mutation 55 autoantibodies 55 microscopic hematuria 55 brain lesions 55 coronary artery disease 55 bladder tumors 55 diverticular bleeding 55 precancerous tissue 55 lymphomas 55 mammary cancers 55 anaplastic 55 ALK mutations 55 lipid lowering medications 55 transaminase levels 55 serum calcium levels 55 pancreatic adenocarcinoma 55 nonfasting triglyceride levels 55 VUR 55 GnRH agonists 55 Radical prostatectomy 55 cerebral infarction 55 schwannomas 55 peritoneal cancer 55 endoscopic ultrasonography 55 histologic subtype 55 mammographic 55 resected 55 pyloric stenosis 55 thyroglobulin 55 perioperative mortality 55 androgen deprivation therapy 55 armpit lymph nodes 55 subependymal giant cell 55 varicocele 55 dysglycemia 55 pleural mesothelioma 55 perimenopausal women 55 thymoma 55 severe periodontitis 55 transurethral resection 55 cytoreductive surgery 55 histopathologic examination 55 GIST tumors 55 myocardial infarctions 55 hematuria 55 ASCUS 55 basal cell cancers 55 carotid plaques 55 cranial irradiation 55 cervical intraepithelial neoplasia 55 Thyroid nodules 55 papillomas 55 amyloid deposition 55 thyroidectomy 55 precancers 55 TT genotype 55 gestational diabetes mellitus 55 excisional biopsy 55 conventional colonoscopy 55 cryptorchidism 55 metastatic RCC 55 postoperative complication 55 elevated LDH 55 thrombotic events 55 hepatic steatosis 55 BRCA2 mutation 55 metastatic lymph nodes 55 digital rectal examination 55 transitional cell carcinoma 55 gastric cancer 55 Adjuvant chemotherapy 55 PGDH 55 noncalcified 54 carcinoid 54 lesion 54 tumor shrinkage 54 HbA1c levels 54 highest quintile 54 precancerous 54 β blockers 54 T2DM 54 malignant lymph nodes 54 hepatocellular carcinoma 54 thyroid cancers 54 germline mutations 54 chromosomal aberrations 54 proteinuria 54 core needle biopsy 54 breast endometrial 54 preterm deliveries 54 HDL2 54 subclinical atherosclerosis 54 polyps growths 54 sarcomatoid 54 adenomatous polyp 54 adnexal mass 54 antigen PSA 54 PNET 54 sentinel lymph nodes 54 endometrioid 54 hepatocellular carcinoma HCC 54 dysplastic nevi 54 fibroadenoma 54 completely resected 54 sentinel node 54 Hashimoto thyroiditis 54 curable cancers 54 metastatic tumors 54 locoregional recurrence 54 postoperative complications 54 invasive ductal carcinoma 54 basal cell carcinoma BCC 54 medically inoperable 54 mediastinal 54 colon cancer 54 dutasteride 54 surgical biopsies 54 adjuvant chemotherapy 54 colorectal carcinomas 54 EUS FNA 54 renal dysfunction 54 corticosteroid therapy 54 ovarian carcinoma 54 artery calcification 54 carotid endarterectomy 54 T1a 54 neuroendocrine tumors 54 hypopharynx 54 cervical neoplasia 54 invasive lobular 54 proliferative diabetic retinopathy 54 pre menopausal 54 intravenous bisphosphonates 54 aminotransferase levels 54 renal cell carcinoma 54 rs# [001] 54 B7 H3 54 lymph node removal 54 basal cell carcinoma 54 Asymptomatic 54 hydronephrosis 54 glycated hemoglobin levels 54 calculi 54 mammographic density 54 nodule 54 BRCA mutation 54 melanoma tumors 54 postoperative mortality 54 μmol L 54 coronary artery calcium 54 haemorrhagic stroke 54 left ventricular dysfunction 54 cTnT 54 underwent surgical resection 54 EXJADE 54 pancreatic tumors 54 rs# [002] 54 prostate cancer metastases 54 biochemical relapse 54 colon polyp 54 seminoma 54 hormone receptor negative 54 postoperative pathology 54 cancerous tumors 54 pre malignant lesions 54 pheochromocytoma 54 hepatocellular carcinomas 54 lymph nodes 54 laryngeal cancers 54 coronary stenosis 54 cerebral microbleeds 54 cystectomy 54 myocardial infarction 54 metastatic cancer 54 dense breasts 54 ALCL 54 paroxysmal AF 54 anal cancers 54 flutamide 54 coronary blockages 54 microemboli 54 tHcy 54 SLNB 54 elevated triglyceride levels 54 polycystic ovary syndrome PCOS 54 lymph node dissection 54 nonischemic 54 sporadic ALS 54 atrophic gastritis 54 comorbidities 54 polyposis 54 esophageal squamous cell carcinoma 54 Malignant tumors 54 K ras mutations 54 thyroid stimulating hormone 54 prostate cancer CRPC 54 carotid IMT 54 intact parathyroid hormone 54 FDG uptake 54 Adenocarcinoma 54 benign nodules 54 pericardial effusion 54 seminal vesicle invasion 54 intensive statin therapy 54 paragangliomas 54 prostate specific 54 astrocytoma 54 atherosclerotic disease 54 curative resection 54 Metastases 54 malignant melanomas 54 nonalcoholic steatohepatitis 54 kidney dysfunction 54 adenoma detection 54 coronary artery calcification 54 T2 lesions 54 lipid lowering therapy 54 sentinel node biopsy 54 CMV disease 54 urate 54 lobectomy 54 #p# [001] 54 hyperhomocysteinemia 54 specific antigen PSA 54 esophageal tumors 54 orchiectomy 54 microcalcifications 54 diverticulosis 53 retinopathy 53 fibrocystic changes 53 beta carotene supplementation 53 H pylori 53 noncardiac 53 intraepithelial neoplasia 53 sentinel lymph node biopsy 53 calcified plaque 53 Invasive Breast Cancer 53 parathyroid 53 hyperparathyroidism 53 urine cytology 53 CMV infection 53 pT3 53 calcified plaques 53 neoadjuvant therapy 53 lipid abnormalities 53 alanine aminotransferase ALT 53 sigmoidoscopy 53 microvascular disease 53 pneumonectomy 53 squamous cells 53 pelvic lymph nodes 53 grade glioma 53 SHBG levels 53 postoperative delirium 53 thiazide diuretics 53 tertile 53 telomere lengths 53 pheochromocytomas 53 underwent resection 53 biliary tract cancer 53 tumor histology 53 oesophageal adenocarcinoma 53 bacteriuria 53 atypical moles 53 ovarian cancer 53 NNRTI resistance 53 platelet reactivity 53 HER2 positive 53 antihypertensive medications 53 precancerous condition 53 neovascular AMD 53 squamous cell carcinoma SCC 53 serum calcium 53 nonmetastatic 53 APOE e4 53 hyperkalemia 53 ductal lobular 53 melanocytic nevi 53 macrosomia 53 tPSA 53 tumor 53 Squamous 53 sonographically 53 atheroma volume 53 basal cell skin 53 EGFR mutation 53 atherosclerotic lesion 53 desmoplastic 53 MMSE scores 53 ocular toxicity 53 diverticula 53 breast cancer subtypes 53 clinically detectable 53 hemorrhagic complications 53 screening colonoscopy 53 oesophageal 53 endometrial thickness 53 cystic lesions 53 impaired fasting glucose 53 colon growths 53 MALT lymphoma 53 pathologic diagnosis 53 adrenocortical cancer 53 osteopenic 53 astrocytomas 53 unresectable tumors 53 FDG PET 53 Cancers 53 biopsies 53 hyperintense lesions 53 metabolic syndrome 53 fibrosis 53 paclitaxel eluting stents 53 lymphocytosis 53 recurrent UTI 53 precancerous colon polyps 53 cardiovascular mortality 53 glioblastomas 53 localized prostate cancer 53 intraductal 53 adjuvant therapy 53 denser breasts 53 cryptogenic stroke 53 lymphovascular invasion 53 endometrial tumors 53 TEAEs 53 rs# [003] 53 incidentalomas 53 venous blood clots 53 CLA supplementation 53 squamous cell lung cancer 53 HER2 expression 53 euthyroid 53 albumin excretion 53 lipoma 53 PIK3CA 53 abnormal mammogram 53 LV dysfunction 53 antihypertensive therapy 53 pancreatic prostate 53 Barrett mucosa 53 ectopic 53 familial ALS 53 cataract formation 53 papillary carcinoma 53 HbA 1c levels 53 invasive cervical cancer 53 narcolepsy cataplexy 53 urothelial cancer 53 cervical lymph nodes 53 ximelagatran 53 varicoceles 53 nodular melanoma 53 bronchioloalveolar carcinoma 53 highest tertile 53 confounding variables 53 intima media thickness 53 white matter hyperintensities 53 inflammatory lesions 53 subclinical 53 thromboses 53 esophagectomy 53 breast tissue 53 papillary thyroid cancer 53 papillary renal cell carcinoma 53 obstructive coronary artery 53 perioperative morbidity 53 adrenal masses 53 NMIBC 53 CT colonography 53 metastatic prostate 53 colorectal 53 partial nephrectomy 53 ipsilateral 53 elevated troponin 53 T1DM 53 endometrial 53 androgen suppression therapy 53 NAT2 53 chronic periodontitis 53 bisphosphonates 53 neurofibromas 53 cystoscopy 53 serum concentrations 53 myomas 53 breast conserving 53 malignant transformation 53 severe hypoglycemia 53 microvascular complications 53 thyroid hormone levels 53 malignant prostate 53 folate intake 53 preoperatively 53 gastrointestinal stromal tumor 53 endosonography 53 mucosal lesions 53 esophagogastric junction 53 prognostic indicator 53 microdeletions 52 prognostic factors 52 oral bisphosphonates 52 F FDG PET 52 basal cell 52 coronary artery stenosis 52 adrenal tumors 52 nonalcoholic steatohepatitis NASH 52 Melanomas 52 normal karyotype 52 parathyroid carcinoma 52 clinically localized prostate 52 prostate TURP 52 rectal carcinoma 52 Colon polyps 52 trans retinoic acid 52 recurrent venous thromboembolism 52 thyroid tumors 52 soft tissue sarcomas 52 pituitary adenomas 52 chlamydial infection 52 surgical biopsy 52 histological subtype 52 pharyngeal cancer 52 HIV HCV coinfected 52 A1Cs 52 viable myocardium 52 atherosclerotic plaques 52 VTE 52 keloids 52 glioma tumors 52 B Cell Lymphoma 52 intravesical therapy 52 hypothyroidism 52 arterial thromboembolic events 52 A1c levels 52 liver biopsies 52 thyrotropin levels 52 POAG 52 pelvic lymphadenectomy 52 CT coronary angiography 52 solar keratosis 52 noncarriers 52 hypermethylation 52 stone formers 52 ALT elevation 52 thrombi 52 R0 resection 52 anastrozole 52 oncologic outcomes 52 epithelial ovarian 52 bowel cancer 52 BRCA gene mutations 52 preoperative PSA 52 histologic 52 intraoperative complications 52 wedge resection 52 familial AF 52 carotid artery thickness 52 metabolically healthy 52 coronary calcium 52 esophagogastroduodenoscopy 52 ascites 52 congenital anomalies 52 LDL particle 52 DXA scan 52 gadolinium enhanced 52 LUTS 52 osteochondromas 52 histologically confirmed 52 HPV infections 52 parenchyma 52 kidney cysts 52 severe neutropenia 52 Cholangiocarcinoma 52 TCF#L# 52 cholelithiasis 52 urate levels 52 familial adenomatous polyposis FAP 52 lung adenocarcinoma 52 breast lumps 52 paricalcitol 52 osteochondroma 52 detect polyps 52 supratentorial 52 lung adenocarcinomas 52 ovulatory infertility 52 fasting glucose levels 52 retroperitoneal 52 parathyroid glands 52 metastatic renal cell carcinoma 52 mL/min/#.# m 2 52 creatinine ratio 52 thromboembolic disease 52 NSCLC tumors 52 thyrotoxicosis 52 IgA deficiency 52 GSTM1 gene 52 undergoing bariatric surgery 52 bone scintigraphy 52 NSCLC 52 APOL1 52 invasive coronary angiography 52 parathyroidectomy 52 Lesions 52 adrenalectomy 52 papillary RCC 52 Uterine fibroids 52 bisphosphonate therapy 52 urolithiasis 52 cytogenetic abnormalities 52 oral antidiabetic medication 52 ependymoma 52 cancerous breast 52 artery stenosis 52 debulking surgery 52 cardiac troponin T 52 extrapyramidal symptoms 52 noncancerous 52 prostate cancer 52 indomethacin 52 reinfarction 52 polypectomy 52 acute leukemias 52 neuroblastoma tumors 52 mIU L 52 ipsilateral stroke 52 pituitary tumors 52 breast biopsies 52 ischemic stroke 52 axillary lymph node 52 chemopreventive agent 52 nonproliferative 52 selenium supplementation 52 hyperplasia 52 ruptured aneurysms 52 bisphosphonate drugs 52 RYGB surgery 52 prostate abnormalities 52 glioblastoma tumors 52 NKX2 52 familial adenomatous polyposis 52 Median survival 52 HER2 positive cancers 52 NSAIDs 52 epithelioid 52 penetrance 52 obese postmenopausal 52 overt hypothyroidism 52 confidence interval CI 52 IGFBP 52 necrotic core 52 pharyngeal cancers 52 giant cell arteritis 52 left ventricular systolic 52 antiplatelet drugs 52 anal lesions 52 ovarian malignancy 52 recurrent miscarriages 52 salpingo oophorectomy 52 sarcomas 52 choriocarcinoma 52 EDSS scores 52 aberrant crypt foci 52 hypercalcemia 52 disease progression 52 TMPRSS2 ERG fusion 52 bone resorption 52 cholangiocarcinoma 52 chest radiography 52 ertapenem 52 #q# [001] 52 Squamous cell carcinomas 52 hippocampal atrophy 52 hip BMD 52 nondiabetics 52 skin cancers 52 precancerous lesion 52 olaparib 52 ECG abnormalities 52 FOBT 52 invasive ductal breast cancer 52 tibolone 52 bisphosphonate 52 metaplasia 52 revascularization procedures 52 serum testosterone 52 lowest tertile 52 elevated triglycerides 52 radical prostatectomy RP 52 cystatin C 52 undergone radical prostatectomy 52 cervical lymph node 52 metastatic lung cancer 52 fasting insulin 52 tamoxifen therapy 52 intestine colon 52 artery blockages 52 irregular menstrual cycles 52 OGG1 52 Surgical resection 52 octreotide LAR 52 antiplatelet therapy 52 TP# mutations 52 colonoscopic 52 LCIS 52 non aspirin NSAIDs 52 EBUS FNA 52 pre cancerous 52 Wilms tumor 52 Barrett Esophagus 52 Biopsies 52 generalized seizures 52 growths 52 H. pylori 52 infarct size 52 hypoperfusion 52 colorectal cancer incidence 52 stage IIIB 52 keloid 52 frequently benign tumor 52 chronic prostatitis 52 HPV infection